SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950116-04-001167
Filing Date
2004-04-08
Accepted
2004-04-08 13:27:25
Documents
3
Period of Report
2004-05-17
Effectiveness Date
2004-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 230190
3 GRAPHIC emptybox.gif GRAPHIC 1218
4 GRAPHIC tickedbox.gif GRAPHIC 1267
  Complete submission text file 0000950116-04-001167.txt   234448
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 04724311
SIC: 2834 Pharmaceutical Preparations